切换至 "中华医学电子期刊资源库"

中华胸部外科电子杂志 ›› 2020, Vol. 07 ›› Issue (04) : 257 -261. doi: 10.3877/cma.j.issn.2095-8773.2020.04.10

所属专题: 总编推荐 经典病例 文献

病例报告

埃克替尼治疗肺腺癌术后脊髓内转移瘤1例并文献综述
王春茂1, 韩鸣1, 张天辉1, 常秀军1, 王子彤1,()   
  1. 1. 101149 北京,首都医科大学附属北京胸科医院,北京市结核病胸部肿瘤研究所胸外一科
  • 收稿日期:2020-10-06 修回日期:2020-11-23 接受日期:2020-11-24 出版日期:2020-11-28
  • 通信作者: 王子彤

Lung adenocarcinoma after surgery with intramedullary spinal cord metastasis successfully treated with Icotinib treatment: a case report and literature review

Chunmao Wang1, Ming Han1, Tianhui Zhang1   

  • Received:2020-10-06 Revised:2020-11-23 Accepted:2020-11-24 Published:2020-11-28
引用本文:

王春茂, 韩鸣, 张天辉, 常秀军, 王子彤. 埃克替尼治疗肺腺癌术后脊髓内转移瘤1例并文献综述[J/OL]. 中华胸部外科电子杂志, 2020, 07(04): 257-261.

Chunmao Wang, Ming Han, Tianhui Zhang. Lung adenocarcinoma after surgery with intramedullary spinal cord metastasis successfully treated with Icotinib treatment: a case report and literature review[J/OL]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2020, 07(04): 257-261.

图1 胸部CT增强轴位图像
图2 MRI增强矢状位图像
1
Chamberlain MC, Baik CS, Gadi VK,et al.Systemic therapy of brain metastases:non-small cell lung cancer,breast cancer,and melanoma[J].Neuro Oncol,2017,19(1): i1-i24.
2
Connolly ES Jr, Winfree CJ, McCormick PC,et al.Intramedullary spinal cord metastasis:report of three cases and review of the literature[J].Surg Neurol,1996,46(4): 329-338.
3
Chason JL, Walker FB, Landers JW.Metastatic carcinoma in the central nervous system and dorsal root ganglia.A prospective autopsy study[J].Cancer,1963,16: 781-787.
4
Koutsis G, Spengos K, Potagas C,et al.Intramedullary spinal cord metastases in a patient with small-cell lung cancer[J].Eur J Intern Med,2006,17(5): 372-374.
5
Murphy KC, Feld R, Evans WK,et al.Intramedullary spinal cord metastases from small cell carcinoma of the lung[J].J Clin Oncol,1983,1(2): 99-106.
6
Sung WS, Sung MJ, Chan JH,et al.Intramedullary spinal cord metastases:a 20-year institutional experience with a comprehensive literature review[J].World Neurosurg,2013,79(3-4): 576-584.
7
Goyal A, Yolcu Y, Kerezoudis P,et al.Intramedullary spinal cord metastases:an institutional review of survival and outcomes[J].J Neurooncol,2019,142(2): 347-354.
8
Schiff D, O'Neill BP.Intramedullary spinal cord metastases:clinical features and treatment outcome[J].Neurology,1996,47(4): 906-912.
9
Potti A, Abdel-Raheem M, Levitt R,et al.Intramedullary spinal cord metastases (ISCM) and non-small cell lung carcinoma (NSCLC):clinical patterns,diagnosis and therapeutic considerations[J].Lung Cancer,2001,31(2-3): 319-323.
10
Hrabalek L.Intramedullary spinal cord metastases:review of the literature[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2010,154(2): 117-122.
11
Payer S, Mende KC, Westphal M, Eicker SO.Intramedullary spinal cord metastases:an increasingly common diagnosis[J].Neurosurg Focus,2015,39(2): E15.
12
Kalayci M, Cağavi F, Gül S,et al.Intramedullary spinal cord metastases:diagnosis and treatment—an illustrated review[J].Acta Neurochir (Wien),2004,146(12): 1347-1354.
13
Lee SS, Kim MK, Sym SJ,et al.Intramedullary spinal cord metastases:a single-institution experience[J].J Neurooncol,2007,84(1): 85-89.
14
Ogino M, Ueda R, Nakatsukasa M,et al.Successful removal of solitary intramedul-lary spinal cord metastasis from colon cancer[J].Clin Neurol Neurosurg,2002,104(2): 152-156.
15
Chi JH, Parsa AT.Intramedullary spinal cord metastasis:clinical management and surgical considerations[J].Neurosurg Clin N Am,2006,17(1): 45-50.
16
Fredericks RK, Elster A, Walker FO.Gadolinium-enhanced MRI:a superior technique for the diagnosis of intraspinal metastases[J].Neurology,1989,39(5): 734-736.
17
Komori T, Delbeke D.Leptomeningeal carcinomatosis and intramedullary spinal cord me-tastases from lung cancer:detection with FDG positron emission tomography[J].Clin Nucl Med,2001,26(11): 905-907.
18
Poggi MM, Patronas N, Buttman JA,et al.Intramedullary spinal cord me-tastasis from renal cell carcinoma:detection by positron emission tomography[J].Clin Nucl Med,2001,26(10): 837-839.
19
Hashii H, Mizumoto M, Kanemoto A,et al.Radiotherapy for patients with symptomatic intrame-dullary spinal cord metastasis[J].J Radiat Res,2011,52(5): 641-645.
20
Lv J, Liu B, Quan X,et al.Intramedullary spinal cord metastasis in malignancies:an institutional analysis and review[J].Onco Targets Ther,2019,12: 4741-4753.
21
Temel JS, Greer JA, Muzikansky A,et al.Early palliative care for patients with metastatic non-small-cell lung cancer[J].N Engl J Med,2010,363(8): 733-742.
22
Levack P, Graham J, Collie D,et al.Don't wait for a sensory level--listen to the symptoms:a prospective audit of the delays in diagnosis of malignant cord compression[J].Clin Oncol (R Coll Radiol),2002,14(6): 472-480.
23
Veeravagu A, Lieberson RE, Mener A,et al.CyberKnife stereotactic radiosurgery for the treatment of intramedullary spinal cord metastases[J].J Clin Neurosci,2012,19(9): 1273-1277.
24
Kalita O.Current insights into surgery for intramedullary spinal cord metastases:a literature review[J].Int J Surg Oncol,2011,2011: 989506.
25
Miura S, Kaira K, Kaira R,et al.The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer:a case series of eight patients[J].Invest New Drugs,2015,33(3): 755-760.
26
Majmundar N, Shao B, Assina R.Lung adenocarcinoma presenting as intramedullary spinal cord metastasis:Case report and review of literature[J].J Clin Neurosci,2018,52: 124-131.
27
张菁华.厄洛替尼治疗肺癌合并脊髓转移1例[J].临床肿瘤学杂志,2012,1(17): 95-96.
28
Minomo S, Tokoro A, Utsumi T,et al.A case of long-term survival after multimodal local treatments of intramedullary spinal cord metastasis of squamous cell lung cancer[J].J Thorac Dis,2016,8(8): E681-E683.
29
Hata Y, Takai Y, Takahashi H,et al.Complete response of 7 years’ duration after chemoradiotherapy followed by gefitinib in a patient with intramedullary spinal cord metastasis from lung adenocarcinoma[J].J Thorac Dis,2013,5(2): E65-E67.
[1] 刘世佳, 陶新楠, 史晋宇, 吕文豪, 张亚芬. 乳酸脱氢酶A在乳腺癌中的作用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(03): 175-179.
[2] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[3] 黄莹, 李璇, 刘梦杨, 彭桂林, 徐鑫, 韦兵, 杨超. 靶向联合治疗双肺移植术后KRAS和BRAF基因双突变晚期肺腺癌一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 298-301.
[4] 吴伟宙, 王琼仁, 詹雄宇, 郑明星, 李亚县. 广东省医学会泌尿外科疑难病例多学科会诊(第16期)——左肾肉瘤样癌[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 525-529.
[5] 李飞, 郑灶松, 吴芃, 谭万龙. 广东省医学会泌尿外科疑难病例多学科会诊(第16期)——延胡索酸水合酶缺陷型晚期肾细胞癌[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 410-414.
[6] 李勇, 彭天明, 王倩倩, 陈育纯, 蒲小勇, 刘久敏. 基于失巢凋亡相关基因的膀胱癌预后模型构建及分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 331-339.
[7] 黄兴, 王蕾, 夏丹. 靶向免疫治疗时代下减瘤性肾切除术在转移性肾细胞癌治疗中的价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 208-213.
[8] 邓永豪, 曹嘉正. 长链非编码RNA与肾癌的关系及其在肾癌中的临床应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 289-293.
[9] 郑琪, 马婕群, 张彦兵, 廖子君, 张锐. EPHA5突变预测肺腺癌免疫检查点抑制剂治疗预后的临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 548-552.
[10] 刘静, 徐爽, 缪亚军. 肺腺癌miR-3653表达与高危型人乳头瘤病毒感染及预后的关系[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 600-604.
[11] 陈伟杰, 何小东. 胆囊癌免疫靶向治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 763-768.
[12] 魏妙艳, 徐近. 合并远处转移胰腺癌系统性治疗的梳理和展望[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 644-650.
[13] 李永政, 孟煜凡, 樊知遥, 展翰翔. 胰腺神经内分泌肿瘤新辅助治疗研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 481-486.
[14] 陆思楠, 苏同荣, 张启逸. 索凡替尼转化治疗胰腺神经内分泌肿瘤肝转移一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 526-530.
[15] 王光伟, 李桂莲, 王勇. 散发性静脉畸形的靶向治疗进展[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 380-385.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?